352
Views
0
CrossRef citations to date
0
Altmetric
Systematic Review

Increased Circulating Interleukin-8 Levels in Systemic Lupus Erythematosus Patients: a Meta-Analysis.

, , , , , & show all
Pages 1291-1302 | Received 24 Jun 2018, Accepted 31 Aug 2018, Published online: 04 Dec 2018

References

  • Mak A , IsenbergDA, LauCS. Global trends, potential mechanisms and early detection of organ damage in SLE. Nat. Rev. Rheumatol.9 ( 5 ), 301 – 310 (2013).
  • Bundhun PK , KumariA, HuangF. Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: a systematic review and meta-analysis. Medicine96 ( 37 ), e8086 (2017).
  • Ahmadpoor P , DaliliN, RostamiM. An update on pathogenesis of systemic lupus erythematosus. Iran J. Kidney Dis.8 ( 3 ), 171 – 184 (2014).
  • Dean GS , Tyrrell-PriceJ, CrawleyE, IsenbergDA. Cytokines and systemic lupus erythematosus. Ann. Rheum. Dis.59, 243 – 251 (2000).
  • Ronnblom L , ElkonKB. Cytokines as therapeutic targets in SLE. Nat. Rev. Rheumatol.6 ( 6 ), 339 – 347 (2010).
  • Dong R , ZhengS. Interleukin-8: a critical chemokine in biliary atresia. J. Gastroenterol. Hepatol.30 ( 6 ), 970 – 976 (2015).
  • Wang J , WangY, WangSet al. Bone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of colorectal cancer. Oncotarget6 ( 40 ), 42825 – 42837 (2015).
  • Lattanzio L , TonissiF, TortaIet al. Role of IL-8 induced angiogenesis in uveal melanoma. Invest. New Drugs31 ( 5 ), 1107 – 1114 (2013).
  • Alfaro C , SanmamedMF, Rodriguez-RuizMEet al. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat. Rev.60, 24 – 31 (2017).
  • Baggiolini MWA , KunkelSl. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest.84 ( 4 ), 1045 – 1049 (1989).
  • Kaplan MJ . Neutrophils in the pathogenesis and manifestations of SLE. Nat. Rev. Rheumatol.7 ( 12 ), 691 – 699 (2011).
  • Thieblemont N , WrightHL, EdwardsSW, Witko-SarsatV. Human neutrophils in auto-immunity. Semin. Immunol.28 ( 2 ), 159 – 173 (2016).
  • Lee KH , KronbichlerA, ParkDDet al. Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review. Autoimmun. Rev.16 ( 11 ), 1160 – 1173 (2017).
  • Hakkim A , FurnrohrBG, AmannKet al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl Acad. Sci. USA107 ( 21 ), 9813 – 9818 (2010).
  • Gupta AK , HaslerP, HolzgreveW, GebhardtS, HahnS. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum. Immunol.66 ( 11 ), 1146 – 1154 (2005).
  • Lit LC , WongCK, TamLS, LiEK, LamCW. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann. Rheum. Dis.65 ( 2 ), 209 – 215 (2006).
  • Nielepkowicz-Gozdzinska A , FendlerW, RobakEet al. Exhaled IL-8 in systemic lupus erythematosus with and without pulmonary fibrosis. Arch. Immunol. Ther. Exp. (Warsz)62 ( 3 ), 231 – 238 (2014).
  • Higgins JP , ThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat. Med.21 ( 11 ), 1539 – 1558 (2002).
  • Higgins JP , ThompsonSG, DeeksJJ, AltmanDG. Measuring inconsistency in meta-analyses. BMJ327 ( 7414 ), 557 – 560 (2003).
  • Egger M , Davey SmithG, SchneiderM, MinderC. Bias in meta-analysis detected by a simple, graphical test. BMJ315 ( 7109 ), 629 – 634 (1997).
  • Pacheco Y , Barahona-CorreaJ, MonsalveDMet al. Cytokine and autoantibody clusters interaction in systemic lupus erythematosus. J. Transl. Med.15 ( 1 ), 239 (2017).
  • Wu Y , CaiB, ZhangJet al. IL-1beta and IL-6 are highly expressed in RF+IgE+ systemic lupus erythematous subtype. J. Immunol Res.2017, 5096741 (2017).
  • Willis R , SmikleM, DeceulaerK, Romay-PenabadZ, PapalardoE, JajoriaP, HarperB, MurthyV, PetriM, GonzalezEB. Clinical associations of proinflammatory cytokines, oxidative biomarkers and vitamin D levels in systemic lupus erythematosus. Lupus26 ( 14 ), 1517 – 1527 (2017).
  • Lopez P , Rodriguez-CarrioJ, Martinez-ZapicoA, Caminal-MonteroL, SuarezA. Senescent profile of angiogenic T cells from systemic lupus erythematosus patients. J. Leukoc. Biol.99 ( 3 ), 405 – 412 (2016).
  • Timoteo RP , MicheliDC, TeodoroRBet al. Characterization of inflammatory markers associated with systemic lupus erythematosus patients undergoing treatment. Rev. Bras. Reumatol. Engl. Ed.56 ( 6 ), 497 – 503 (2016).
  • Wu B , WangW, ZhanYet al. CXCL13, CCL4, and sTNFR as circulating inflammatory cytokine markers in primary and SLE-related autoimmune hemolytic anemia. J. Transl Med.13 ( 1 ), 112 (2015).
  • Wang JB , LiH, WangLL, LiangHD, ZhaoL, DongJ. Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous. Int. J. Clin. Exp. Med.8 ( 9 ), 16658 – 16663 (2015).
  • Guo Y , ChaiQ, ZhaoY, LiP, QiaoJ, HuangJ. Increased activation of toll-like receptors-7 and -8 of peripheral blood mononuclear cells and upregulated serum cytokines in patients with pediatric systemic lupus erythematosus. Int. J. Clin. Exp. Med.8 ( 11 ), 20472 – 20480 (2015).
  • Yin Z , HuangJ, HeWet al. Serum level of eight cytokines in Han Chinese patients with systemic lupus erythematosus using multiplex fluorescent microsphere method. Cent. Eur. J. Immunol.39 ( 2 ), 228 – 235 (2014).
  • Hrycek E , FranekA, BlaszczakE, DworakJ, HrycekA. Serum levels of selected chemokines in systemic lupus erythematosus patients. Rheumatol. Int.33 ( 9 ), 2423 – 2427 (2013).
  • Hermansen ML , HummelshojL, LundsgaardDet al. Increased serum beta2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients. Lupus21 ( 10 ), 1098 – 1104 (2012).
  • Avrămescu C , BiciuşcăV, DăianuTet al. Cytokine panel and histopathological aspects in the systemic lupus erythematosus. Rom. J. Morphol. Embryol.51 ( 4 ), 633 – 640 (2010).
  • Ma Y , LX-L, DuG-Z, XuG-L. Changes in serum level of IL-6, IL-8 in active patiets with systemic lupus erythematosus and its clinic value. Journal of Dalian Medical University.29 ( 5 ), 497 – 498 (2007).
  • Asanuma Y , ChungCP, OeserA, ShintaniA, StanleyE, RaggiP, SteinCM. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J. Rheumatol.33 ( 3 ), 539 – 545 (2006).
  • Ohlsson S , HellmarkT, PietersK, SturfeltG, WieslanderJ, SegelmarkM. Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis. Clin. Exp. Immunol.141 ( 1 ), 174 – 182 (2005).
  • Tesar V , MasekZ, RychlíkIet al. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol. Dial. Transplant.13 ( 7 ), 1662 – 1667 (1998).
  • Mohan T , ZhuW, WangY, WangBZ. Applications of chemokines as adjuvants for vaccine immunotherapy. Immunobiology223 ( 6–7 ), 477 – 485 (2018).
  • Baggiolini M , WalzA, KunkelSl. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest.84 ( 4 ), 1045 – 1049 (1989).
  • Baggiolini M , Clark-LewisI. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett.307 ( 1 ), 97 – 101 (1992).
  • Lotti F , MaggiM. Interleukin 8 and the male genital tract. J. Reprod. Immunol.100 ( 1 ), 54 – 65 (2013).
  • Cavusoglu E , MarmurJD, YanamadalaSet al. Elevated baseline plasma IL-8 levels are an independent predictor of long-term all-cause mortality in patients with acute coronary syndrome. Atherosclerosis242 ( 2 ), 589 – 594 (2015).
  • Shin WS SA , RocksonSG. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis160 ( 1 ), 91 – 102 (2002).
  • Bundhun PK , BoodhooKD, LongMY, ChenMH. Impact of antiphospholipid syndrome and/or systemic lupus erythematosus on the long-term adverse cardiovascular outcomes in patients after percutaneous coronary intervention: a systematic review and meta-analysis. Medicine95 ( 12 ), e3200 (2016).
  • Trysberg ETA . Cerebral inflammation and degeneration in systemic lupus erythematosus. Curr. Opin. Rheumatol.16 ( 5 ), 527 – 533 (2004).
  • Pitman H , InnesBA, RobsonSC, BulmerJN, LashGE. Altered expression of interleukin-6, interleukin-8 and their receptors in decidua of women with sporadic miscarriage. Hum. Reprod.28 ( 8 ), 2075 – 2086 (2013).
  • Bundhun PK , SoogundMZ, HuangF. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001-2016. J. Autoimmun.79, 17 – 27 (2017).
  • Tower C , CrockerI, ChiricoD, BakerP, BruceI. SLE and pregnancy: the potential role for regulatory T cells. Nat. Rev. Rheumatol.7 ( 2 ), 124 – 128 (2011).
  • Sung HJ , ChoiS, LeeJWet al. Inhibition of human neutrophil activity by an RNA aptamer bound to interleukin-8. Biomaterials35 ( 1 ), 578 – 589 (2014).
  • Zeilhofer Hu SW . Role of interleukin-8 in neutrophil signaling. Curr. Opin. Hematol.7 ( 3 ), 178 – 182 (2000).
  • Seitz M , DewaldB, GerberN, BaggioliniM. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J. Clin. Invest.87 ( 2 ), 463 – 469 (1991).
  • Beaulieu AD , McCollSR. Differential expression of two major cytokines produced by neutrophils, interleukin-8 and the interleukin-1 receptor antagonist, in neutrophils isolated from the synovial fluid and peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum.37 ( 6 ), 855 – 859 (1994).
  • Grayson PC , KaplanMJ. At the Bench: neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases. J. Leukoc. Biol.99 ( 2 ), 253 – 264 (2016).
  • Mahajan A , HerrmannM, MunozLE. Clearance deficiency and cell death pathways: a model for the pathogenesis of SLE. Front. Immunol.7, 35 (2016).
  • Petrackova A , SmrzovaA, GajdosPet al. Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay. Clin. Proteomics14, 32 (2017).
  • Sekikawa T , KashiharaN, MaruyamaKet al. Expression of interleukin-8 in human glomerulonephritis. Res. Commun. Mol. Pathol. Pharmacol.99 ( 2 ), 217 – 224 (1998).
  • Tsai CY , WuTH, YuCL, LuJY, TsaiYY. Increased excretions of β 2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm–Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron85 ( 3 ), 207 – 214 (2000).
  • Holcombe RF , BaethgeBA, WolfREet al. Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus. Lupus3 ( 2 ), 97 – 102 (1994).
  • Al-Mutairi S , Al-AwadhiA, RaghupathyRet al. Lupus patients with pulmonary involvement have a pro-inflammatory cytokines profile. Rheumatol. Int.27 ( 7 ), 621 – 630 (2007).
  • Trysberg ECH , TarkowskiA. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus9 ( 7 ), 498 – 503 (2000).
  • Lu XY , ZhuCQ, QianJ, ChenXX, YeS, GuYY. Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection. Lupus19 ( 6 ), 689 – 695 (2010).
  • Yung S , NgCY, AuKYet al. Binding of anti-dsDNA antibodies to proximal tubular epithelial cells contributes to renal tubulointerstitial inflammation. Clin. Sci. (Lond).131 ( 1 ), 49 – 67 (2017).
  • Gunawan M , HerZ, LiuMet al. A novel human systemic lupus erythematosus model in humanised mice. Sci. Rep.7 ( 1 ), 16642 (2017).
  • Pan HF , LengRX, FengCCet al. Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus. Mol. Biol. Rep.40 ( 1 ), 391 – 399 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.